Hypothesis

Iron availability in colonic crypts operates as a bistable regulator of TET enzyme activity, creating two epigenetically distinct stem‑cell states: a youthful state with low Wnt‑gene methylation and an aged state exhibiting ACCA drift. Restoration of intracellular iron(II) not only reactivates TET demethylation but also triggers a butyrate‑dependent upregulation of ferroportin (FPN), exporting excess iron and preventing re‑accumulation of oxidative stress that drives further drift.

Mechanistic Basis

• Iron(II) is a cofactor for TET enzymes; its loss in aging crypts reduces 5‑mC oxidation, allowing DNMT‑mediated hypermethylation of Wnt regulators (see iron‑TET link) [3].
• Butyrate, a bacterial fermentation product, inhibits HDACs, increasing transcription of the iron‑export gene FPN and the iron‑storage gene ferritin light chain (FTL) via heightened histone acetylation at their promoters.
• Elevated FPN exports cytosolic iron(II), lowering the labile iron pool and reducing Fenton‑mediated ROS that would otherwise oxidize TET cofactors and promote DNMT3B activity.
• Thus, a butyrate‑iron feedback loop can lock crypts in a low‑methylation, low‑ROS state, reversing ACCA drift.

Testable Predictions

1. Crypts isolated from proximal colon (higher butyrate exposure) will show higher FPN expression, higher labile iron(II), and lower ACCA‑associated methylation than distal crypts.
2. Acute iron chelation with deferoxamine in colonic organoids will increase TET activity and decrease methylation at the 15 CRC‑associated CpG sites within 72 h.
3. Supplementation of butyrate (5 mM) to iron‑depleted organoids will rescue FPN expression, restore intracellular iron(II) to youthful levels, and reduce ACCA drift methylation by >30 % relative to untreated controls.
4. In vivo, mice fed a high‑butyrate diet will exhibit slower accumulation of ACCA drift methylation over 12 months compared with control diet, as measured by longitudinal bisulfite sequencing of isolated crypts.

Experimental Approach

• Sample collection: Laser‑capture microdissection of individual crypts from proximal, mid, and distal colon of young (3 mo) and aged (24 mo) mice; parallel human biopsies from screening colonoscopies.
• Assays: Labile iron(II) measured by Calcein‑AM quenching; TET activity gauged by 5‑hmC dot blot; methylation profiling of ACCA CpG panel and the 15 CRC‑linked CpGs via targeted bisulfite amplicon sequencing; FPN and FTL mRNA by qPCR; HDAC activity assay.
• Interventions: Treat organoids with deferoxamine (100 µM), ferrous sulfate (50 µM), sodium butyrate (5 mM), or combinations; include HDAC inhibitor (trichostatin A) as control for butyrate‑specific effects.
• Read‑outs: Changes in methylation percentage at each CpG over time (0, 24, 72, 168 h); correlation with iron(II) levels and FPN expression.
• Statistical plan: Two‑way ANOVA with factors treatment and region; post‑hoc Tukey; significance set at p < 0.05; power analysis targeting 80 % power to detect 20 % methylation shift.

If butyrate‑mediated iron export fails to lower methylation despite restoring iron(II), the hypothesis that iron‑TET dynamics are the primary driver of ACCA drift would be falsified, prompting investigation of alternative mechanisms such as direct metabolite inhibition of DNMTs or altered nucleosome positioning.